• 1. Fe3O4/FeS2 heterostructures enable efficient oxygen evolution reaction?
  Xingqun Zheng,Lele Song,Xin Feng,Li Li,Zidong Wei J. Mater. Chem. A, 2020,8, 14145-14151
• 2. Elusive 2-aminofuran Diels–Alder substrates for a straightforward synthesis of polysubstituted anilines?
  Ana G. Neo,Ana Bornadiego,Jesús Díaz,Stefano Marcaccini,Carlos F. Marcos Org. Biomol. Chem., 2013,11, 6546-6555
• 3. Enantiomeric helical TiO2 nanofibers modulate different peptide assemblies and subsequent cellular behaviors?
  Xu Jie,Deng Xu,Weili Wei RSC Adv., 2019,9, 29149-29153
• 4. Distribution and ecological risk assessment of typical antibiotics in the surface waters of seven major rivers, China?
  Environ. Sci.: Processes Impacts, 2021,23, 1088-1100
• 5. Exceptionally high temperature spin crossover in amide-functionalised 2,6-bis(pyrazol-1-yl)pyridine iron(ii) complex revealed by variable temperature Raman spectroscopy and single crystal X-ray diffraction?
  Max Attwood,Hiroki Akutsu,Lee Martin,Toby J. Blundell,Pierre Le Maguere,Scott S. Turner Dalton Trans., 2021,50, 11843-11851

Introduction to 4-methyl-6-(trifluoromethyl)pyrimidine-2-carboxylic acid (CAS No. 1379313-04-8)

4-methyl-6-(trifluoromethyl)pyrimidine-2-carboxylic acid, identified by the CAS number 1379313-04-8, is a significant compound in the field of pharmaceutical and agrochemical research. Its molecular structure, featuring a pyrimidine core with substituents such as a methyl group at the 4-position and a trifluoromethyl group at the 6-position, along with a carboxylic acid functionality at the 2-position, makes it a versatile intermediate for synthesizing various biologically active molecules.

The compound's unique structural attributes have garnered attention in recent years due to its potential applications in drug discovery and development. The presence of the trifluoromethyl group, in particular, is well-documented for its ability to enhance metabolic stability, lipophilicity, and binding affinity in drug candidates. This feature has made 4-methyl-6-(trifluoromethyl)pyrimidine-2-carboxylic acid a valuable building block for medicinal chemists seeking to optimize pharmacokinetic profiles of their synthetic molecules.

Recent advancements in synthetic methodologies have further highlighted the utility of this compound. Researchers have demonstrated efficient synthetic routes to 4-methyl-6-(trifluoromethyl)pyrimidine-2-carboxylic acid that leverage modern catalytic techniques and green chemistry principles. These methods not only improve yield and purity but also minimize waste, aligning with the growing emphasis on sustainable practices in chemical synthesis.

In the realm of pharmaceutical research, 4-methyl-6-(trifluoromethyl)pyrimidine-2-carboxylic acid has been explored as a precursor for various therapeutic agents. For instance, its structural framework is closely related to nucleoside analogs, which are widely used in antiviral and anticancer therapies. The carboxylic acid moiety provides a handle for further functionalization, enabling the attachment of pharmacophores that target specific biological pathways. Such modifications have led to the discovery of novel compounds with promising preclinical activity.

The agrochemical industry has also benefited from the versatility of 4-methyl-6-(trifluoromethyl)pyrimidine-2-carboxylic acid. Its derivatives have been investigated as intermediates for herbicides and fungicides, where the trifluoromethyl group contributes to enhanced pesticidal activity by improving binding interactions with biological targets. This has spurred interest in developing new generation crop protection agents based on this scaffold.

From a chemical biology perspective, 4-methyl-6-(trifluoromethyl)pyrimidine-2-carboxylic acid serves as a useful tool for studying enzyme inhibition and receptor binding. Its structural features allow it to mimic natural pyrimidine derivatives, making it valuable for probing biological mechanisms at the molecular level. Such studies contribute to our understanding of disease pathways and aid in the development of targeted therapeutics.

The synthesis of 4-methyl-6-(trifluoromethyl)pyrimidine-2-carboxylic acid involves multi-step organic reactions that require precise control over reaction conditions. Advanced spectroscopic techniques such as NMR and mass spectrometry are employed to monitor reaction progress and confirm product identity. These analytical methods ensure high purity standards, which are critical for downstream applications in pharmaceuticals and agrochemicals.

Future research directions may explore novel derivatives of 4-methyl-6-(trifluoromethyl)pyrimidine-2-carboxylic acid with tailored properties for specific applications. For example, incorporating additional functional groups could enhance bioavailability or improve tissue selectivity in drug delivery systems. Similarly, modifications aimed at increasing environmental compatibility may open doors for greener synthetic routes.

In summary, 4-methyl-6-(trifluoromethyl)pyrimidine-2-carboxylic acid (CAS No. 1379313-04-8) is a multifaceted compound with significant potential in pharmaceutical and agrochemical innovation. Its unique structural features, coupled with recent advances in synthetic chemistry, make it an indispensable tool for researchers striving to develop next-generation therapeutics and crop protection agents.

• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)